AXIM BIOTECHNOLOGIES, INC. Proceeds from Sale and Maturity of Marketable Securities
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Proceeds from Sale and Maturity of Marketable Securities of $0 for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-04-19.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2022-04-19
- AXIM BIOTECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2019-12-31 was $198.18K.
- AXIM BIOTECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2018-12-31 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for fiscal 2021 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- AXIM BIOTECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for fiscal 2019 was $375.68K.
- AXIM BIOTECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for fiscal 2018 was $0.00.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 10-K/A · filed 2022-04-19 | ||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-04-19 | $0.00 10-K/A · filed 2022-04-19 | |
| 2020-09-30 | $0.00 10-Q/A · filed 2020-11-27 | ||
| 2019-12-31 | $198.18K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2021-04-26 | $375.68K 10-K/A · filed 2021-04-26 | |
| 2019-09-30 | $177.49K 10-Q/A · filed 2020-11-27 | ||
| 2018-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-05-20 | $0.00 10-K/A · filed 2020-05-20 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 |